| Autor: |
Ng, Cheryl Chun Man, Leung, Alexander Moon Ho |
| Zdroj: |
Journal of Clinical Rheumatology and Immunology; November 2023, Vol. 23 Issue: 1 p51-55, 5p |
| Abstrakt: |
Anti-melanoma differentiation-associated gene 5 (MDA5) antibody positive dermatomyositis is known to associate with rapidly progressive interstitial lung disease and cutaneous ulcer. The prognosis is often poor even with intensive treatment, with data from the local cohort showing 37.9% mortality [1]. Here, we report a case of refractory anti-MDA5 antibody-associated dermatomyositis that occurs shortly after COVID-19 infection and was managed using a combination of treatments that target different aspects of disease pathology. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
